Interruptible demyelination in avian riboflavin deficient neuropathy
- PMID: 38649908
- PMCID: PMC11036723
- DOI: 10.1186/s13578-024-01233-5
Interruptible demyelination in avian riboflavin deficient neuropathy
Abstract
Background and aims: The evolution of demyelination in individual internodes remains unclear although it has been noticed the paranodal demyelination precedes internodal demyelination in neuropathies with diverse aetiologies. For therapeutic purpose, it is fundamental to know whether the demyelinating procedure in affected internodes can be interrupted. This study aimed to delineate the development of demyelination in individual internodes in avian riboflavin deficient neuropathy.
Methods: Newborn broiler meat chickens were maintained either on a routine diet containing 5.0 mg/kg riboflavin, a riboflavin deficient diet containing 1.8 mg/kg riboflavin, or initially a riboflavin deficient diet for 11 days and then routine diet plus riboflavin repletion from day 12. Evolution of demyelination in individual internodes was analyzed by teased nerve fibre studies from day 11 to 21.
Results: In riboflavin deficient chickens, demyelination was the predominant feature: it was mainly confined to the paranodal region at day 11; extended into internodal region, but less than half of the internodal length in most affected internodes at day 16; involved more than half or whole internode at day 21. In the internode undergoing demyelination, myelin degeneration of varying degrees was noticed in the cytoplasm of the Schwann cell wrapping the internode. Two days after riboflavin repletion, co-existence of remyelination and active demyelination within individual internodes was noticed. Remyelination together with preserved short original internodes was the characteristic feature 4 and 9 days after riboflavin repletion.
Conclusion: Riboflavin repletion interrupts the progression from paranodal to internodal demyelination in riboflavin deficient chickens and promotes remyelination before complete internodal demyelination.
Keywords: Demyelination; Remyelination; Riboflavin; Schwann cell; Teased nerve fibre.
© 2024. Crown.
Conflict of interest statement
The author does not have competing interests.
Figures



Similar articles
-
Early paranodal myelin swellings (tomacula) in an avian riboflavin deficiency model of demyelinating neuropathy.Exp Neurol. 2006 Mar;198(1):65-71. doi: 10.1016/j.expneurol.2005.10.028. Epub 2005 Dec 5. Exp Neurol. 2006. PMID: 16336963
-
Schwann cell proliferation and migration during paranodal demyelination.J Neurosci. 1987 Mar;7(3):682-99. doi: 10.1523/JNEUROSCI.07-03-00682.1987. J Neurosci. 1987. PMID: 3559707 Free PMC article.
-
Simulating mild systematic and focal demyelinating neuropathies: membrane property abnormalities.J Integr Neurosci. 2006 Dec;5(4):595-623. doi: 10.1142/s0219635206001331. J Integr Neurosci. 2006. PMID: 17245824
-
Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells.Cell Mol Life Sci. 2020 Jul;77(13):2497-2506. doi: 10.1007/s00018-019-03431-8. Epub 2019 Dec 28. Cell Mol Life Sci. 2020. PMID: 31884566 Free PMC article. Review.
-
The conceptual introduction of the "demyelinating Schwann cell" in peripheral demyelinating neuropathies.Glia. 2019 Apr;67(4):571-581. doi: 10.1002/glia.23509. Epub 2018 Oct 30. Glia. 2019. PMID: 30378179 Review.
References
-
- Dyck PJ, Dyck PJB, Engelstad J, et al. Pathologic alterations of nerve. In: Dyck PJ, Thomas PK, Griffin J, et al., editors. Peripheral neuropathy. 4. Philadelphia, PA: Elsevier; 2005. pp. 733–829.
LinkOut - more resources
Full Text Sources